Fibre Extrusion Technology (FET) of Leeds, UK, enjoyed a highly successful debut at Compamed 2024, the leading international trade fair for the medical technology supplier sector held in Düsseldorf, Germany.

Interest in FET’s technologies reflects the company’s growing role in the global medical sector – in 2023-24, over 60% of FET’s turnover was derived from the medical market.

“It’s never certain whether a new exhibition will prove to be a successful venture until it’s tested in practice but we are delighted to report that Compamed 2024 exceeded all of our expectations,” says FET managing director Richard Slack, “In fact, we have already booked a stand for this year’s exhibition in November.”

Compamed attracts the suppliers of a comprehensive range of high-quality medical technology components, services and production equipment for the medical industry and FET’s expertise in this sector proved to be a perfect fit, with almost 40 serious customer leads taken at the show.

FET’s established expertise lies in laboratory and pilot melt spinning equipment for a vast range of applications, especially precursor materials used in high value medical devices and specialised novel fibres from exotic and difficult to process polymers. In cases where melt spinning solutions are not suitable, FET provides a viable alternative with pilot and small scale production wet spinning systems.

Central to FET’s success has always been its ability to provide customers with advanced testing facilities and equipment at its Fibre Development Centre in Leeds, complemented by unrivalled knowledge and expertise in research and production techniques.

FET has successfully processed over 100 different polymer types in collaboration with specialist companies worldwide and its systems can melt spin resorbable polymers in multifilament, monofilament and nonwoven formats.

www.fetuk.com